Percheron Therapeutics (ASX:PER) warned shareholders about an unauthorized letter and pre-filled proxy form sent by requisitioning shareholder Powerhouse Ventures ahead of its April 24 general meeting, according to a Tuesday filing with the Australian bourse.
The documents, which falsely appeared to be from Percheron, directly reply to an unknown third party not approved to handle proxies, the filing said.
The company urged shareholders to submit forms directly to its registry, Boardroom, to ensure validity.
Shares of the company fell 17% in recent Tuesday trade
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。